David Jordan

Murdoch University

Papers

4

Total Citations

33

H-Index

3

About

David Jordan is a researcher at the forefront of antimicrobial resistance (AMR) surveillance, specializing in the development of innovative, high-throughput technologies to address one of modern medicine's most pressing challenges. His most significant contribution is the development of the Robotic Antimicrobial Susceptibility Platform (RASP), a groundbreaking system that revolutionizes AMR monitoring by overcoming the scalability limitations that have long constrained traditional surveillance programs. First introduced in 2021 and garnering nearly 30 citations across related publications, RASP enables large-scale, affordable screening that was previously impractical in conventional laboratory settings. Jordan's work is deeply embedded in the One Health framework, recognizing the interconnectedness of human, animal, and environmental health. His research has demonstrated RASP's power in detecting the transnational spread of fluoroquinolone-resistant *Escherichia coli* in poultry and identifying resistance in companion animals such as dogs — populations often overlooked in national surveillance efforts. By dramatically expanding the number of organisms that can be analyzed, Jordan's platform offers a transformative approach to early detection of emerging resistance threats, with significant implications for global public health policy and food safety.

Research Focus

Key Achievements

3
H-Index
4
Papers
33
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance
24 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Murdoch University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago